Combivir - 11819-359-10 - (Lamivudine and Zidovudine)

Alphabetical Index


Drug Information of Combivir

Product NDC: 11819-359
Proprietary Name: Combivir
Non Proprietary Name: Lamivudine and Zidovudine
Active Ingredient(s): 150; 300    mg/1; mg/1 & nbsp;   Lamivudine and Zidovudine
Administration Route(s): ORAL
Dosage Form(s): TABLET, COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Combivir

Product NDC: 11819-359
Labeler Name: HHS/Program Support Center/Supply Service Center
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020857
Marketing Category: NDA
Start Marketing Date: 19970930

Package Information of Combivir

Package NDC: 11819-359-10
Package Description: 10 TABLET, COATED in 1 BOTTLE (11819-359-10)

NDC Information of Combivir

NDC Code 11819-359-10
Proprietary Name Combivir
Package Description 10 TABLET, COATED in 1 BOTTLE (11819-359-10)
Product NDC 11819-359
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Lamivudine and Zidovudine
Dosage Form Name TABLET, COATED
Route Name ORAL
Start Marketing Date 19970930
Marketing Category Name NDA
Labeler Name HHS/Program Support Center/Supply Service Center
Substance Name LAMIVUDINE; ZIDOVUDINE
Strength Number 150; 300
Strength Unit mg/1; mg/1
Pharmaceutical Classes Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]

Complete Information of Combivir


General Information